40
2021Hamell Ltd
AGENCY STATEMENT
Hamell is a truly different, award-winning, full service integrated communications agency. We’re a team of creatives, scientists & behaviouralists, driven by evidence & insight. We go beyond what people are doing, to why they are doing it, creating meaningful solutions & communications for better.

- Agency description
We stand out from the crowd.
We don’t just talk about health behaviour, we live it. We get beyond what people are doing, to why they are doing it
Our evidence-based approach means we gain a complete behavioural picture of the environment, with clarity in the core drivers, motivators and barriers experienced by our audience.
When we translate these into meaningful creative, we know that they are tailored to resonate on a deeper level and deliver improved, life-changing outcomes for people.
Nothing is missed. Nothing is misunderstood. Nothing is left to chance.
We make a change for better.
Making change happen is all down to our rigorously tested approach:
- Understanding our audience uncovers deep behavioural insights into the ‘why’ as well as the ‘what. That’s why the first thing we do is undertake a robust behavioural analysis of our audiences – who they are as people, their attitudes and beliefs.
- We then identify the need by using our deep insights to define barriers and motivations. With a distinct strategy in mind, we shape the desired behaviour change for our audience to achieve the best outcomes.
- Whatever comes next, is for the better. Our well established, academically respected approach pushes us beyond the norm with better, more targeted, contextual communication and ultimately, better results.
Our services& specialties.
It takes a collective of behavioural scientists, medical writers, data analysts, researchers, account planners, strategists, client partners, design thinkers and creative communicators to understand the need for better:
- Behavioural research
- POM-P-GSL switch
- Self-care
- Patient engagement
- RWE
- Effective creative
- Medical education
Whatever the service, we work across the entire product lifecycle, from market preparation and disease awareness to non-promotional and promotional communications.
We work across all audiences within the healthcare spectrum, from patients, carers and patient organisations through to consultants, doctors, pharmacists and nurses.
Getting to the why.
We want to understand why people prescribe, recommend, seek help, interpret symptoms, buy or stay on the treatments they do.
Identifying a person’s core and higher emotional drivers plays a pivotal role in uncovering the complicated processes which drive behaviour.
We uncover people’s motivations, what their barriers are, the tone of language they use, their level of self efficacy, how they interpret their symptoms and condition.
This complete, evidence-based picture of behaviour, enables us to predict and ultimately change behaviour.
We understand why people behave in a certain way, rather than making assumptions on what’s seen or reported.
We observe, listen and talk. We look at individuals and groups and analyse verbal and non-verbal cues, actions and emotions.
- Contact details
- 1st Floor Dome Building, The Quadrant Richmond TW9 1DT
- 0207 978 5206
- info@hamell.co.uk
- http://www.hamell.co.uk
- Key contact
- Fiona Hammond
- Managing Director
- fiona@hamell.co.uk
- 2021 Agency Data
-
2020 awardsTotal staff10-24 staffBillings from UK creative healthcare workHealthcare staff20-29 staffTotal agency billingsAgency ageBetween 10 and 15 yearsSocial media footprintStatusINDEPENDENTApproximate percentage of advertising, branding, creative or design work in the UK healthcare market60-69%
- This information was supplied or confirmed by Hamell Ltd. Bar charts are indicative only, with 100% being the maximum score allocated across all agencies. Billings from UK creative healthcare work are not a subset of total annual billings, and so may show a higher rating.
- Ranking factors contributing to agency score
- This chart shows the relative factors that contributed to the agency's overall ranking.
Latest content from Hamell Ltd on PMHub
- Unfinished Plans featured in Daily Mail as actor urges young people struggling with thoughts of suicide to speak out
- Oliver Devoti, who appeared in Unfinished Plans, created in partnership with PAPYRUS as part of the ‘Creativity for Good’ Campaign, shares his very personal story of how suicide has impacted his life and urges young people to seek help.
Hamell - Hamell selected by PM Society's 'Creativity for Good' initiative
- Hamell have been selected by the PM Society’s charity partner PAPYRUS Prevention of Young Suicide, to develop a fundraising campaign as part of their 'Creativity for Good' initiative
Hamell - Marc Greener joins Hamell as their Creative Director, reuniting with Frank Walters
- Marc Greener has joined behaviour-led communications experts Hamell.
Hamell



COVID-19 Updates and Daily News
Featured jobs
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
Quick links
Latest intelligence
- Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
- Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
- Bristol Myers Squibb announces positive trial results for treatment of MS
- My journey advancing the science in pulmonary hypertension
- NHS App to revolutionise digital health and care with major digital updates by 2023
- A new era for UK-Japanese scientific research relations
- Innovative Health Initiative launches first two calls for proposals to tackle ‘biggest’ health research challenges
- Pfizer and BioNTech share positive results for Omicron-adapted COVID-19 vaccine
- New Omicron sub-variants cause COVID-19 cases to rise in the UK
- Novartis announces positive phase 3 trial results for advanced oesophageal cancer
- Sanofi Global Health unveils new nonprofit Impact brand
- Pfizer announces commitment to achieve Net-Zero Standard by 2040
- NICE issues final draft recommending Novartis’ Scemblix to treat chronic myeloid leukaemia
- Alzheimer's Research UK supports government plans for clinical research
- A creative awakening – how pharma is bringing innovation to the patient journey
- Behaviour change – a maze of decisions influenced by personal habits, experiences and intentions
- My journey advancing the science in pulmonary hypertension
- Pfizer and BioNTech share positive results for Omicron-adapted COVID-19 vaccine
- Novartis publishes final positive phase 3 results of Zolgensma in Nature Medicine
- Delivering content to fuel omnichannel engagement
Nucleus Global
Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 800 experts delivering world-class...